Skeletal muscle mass is associated with erythropoietin response in hemodialysis patients

Abstract Background Hyporesponsiveness to erythropoietin stimulating agent (ESA) is associated with poor outcomes in patients with chronic kidney disease. Although ESA hyporesponsiveness and sarcopenia have a common pathophysiological background, clinical evidence linking them is scarce. The purpose...

Full description

Bibliographic Details
Main Authors: Tomoaki Takata, Yukari Mae, Kentaro Yamada, Sosuke Taniguchi, Shintaro Hamada, Marie Yamamoto, Takuji Iyama, Hajime Isomoto
Format: Article
Language:English
Published: BMC 2021-04-01
Series:BMC Nephrology
Subjects:
ESA
Online Access:https://doi.org/10.1186/s12882-021-02346-6